A meta-analysis of five RCTs reported that melatonin significantly elevated AST levels and decreased GGT levels in patients with NAFLD, with no substantial effect on serum ALT levels [63]. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.